Modulation of CD4+ T-cell activation by CD95 co-stimulation

Cell Death and Differentiation

Volumn 18, Issue 4, 2011, Pages 619-631

  Paulsen, M ^a   Valentin, S ^a   Mathew, B ^a   Adam Klages, S ^a   Bertsch, U ^a   Lavrik, I ^b   Krammer, P H ^b   Kabelitz, D ^a   Janssen, O ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CD95; co stimulation; signal transduction; T cell activation

Indexed keywords

CASPASE 3; CASPASE 8; CD3 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL LEVEL; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD3; ANTIGENS, CD95; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYTOKINES; FAS LIGAND PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMOBILIZED PROTEINS; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NUCLEAR PROTEINS; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 79952629569     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.134     Document Type: Article

References (40)

1. Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109: 295-299. (Pubitemid 34141801)
2. Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30: 180-192.
3. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993; 178: 2231-2235. (Pubitemid 23344883)
4. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
5. Alam A, Cohen LY, Aouad S, Sekaly RP. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999; 190: 1879-1890. (Pubitemid 30013853)
6. Maksimow M, Soderstrom TS, Jalkanen S, Eriksson JE, Hanninen A. Fas costimulation of naive CD4T cells is controlled by NF-kappaB signaling and caspase activity. J Leukoc Biol 2006; 79: 369-377. (Pubitemid 44831169)
7. Kataoka T, Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol Cell Biol 2004; 24: 2627-2636.
8. Golks A, Brenner D, Krammer PH, Lavrik IN. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med 2006; 203: 1295-1305. (Pubitemid 43736598)
9. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol 2007; 7: 532-542. (Pubitemid 46987784)
10. Paulsen M, Ussat S, Jakob M, Scherer G, Lepenies I, Schütze S et al. Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes. Eur J Immunol 2008; 38: 1979-1987.
11. Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003; 14: 53-66. (Pubitemid 36098431)
12. Strauss G, Lindquist JA, Arhel N, Felder E, Karl S, Haas TL et al. CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling. J Exp Med 2009; 206: 1379-1393.
13. Crotzer VL, Mabardy AS, Weiss A, Brodsky FM. T cell receptor engagement leads to phosphorylation of clathrin heavy chain during receptor internalization. J Exp Med 2004; 199: 981-991. (Pubitemid 38481089)
14. Schütze S, Tchikov V, Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008; 9: 655-662. (Pubitemid 352032925)
15. Falk M, Ussat S, Reiling N, Wesch D, Kabelitz D, Adam-Klages S. Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. J Immunol 2004; 173: 5077-5085. (Pubitemid 39387790)
16. Janssen O, Scheffler A, Kabelitz D. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Drug Research 1993; 43: 1221-1227.
17. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK et al. The CD95 receptor: apoptosis revisited. Cell 2007; 129: 447-450. (Pubitemid 46660984)
18. Strauss G, Osen W, Knape I, Jacobsen EM, Muller SM, Debatin KM. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity. Cell Death Differ 2007; 14: 480-488.
19. Lavrik IN, Golks A, Riess D, Bentele M, Eils R, Krammer PH. Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 2007; 282: 13664-13671. (Pubitemid 47100557)
20. Alcover A, Alarcon B. Internalization and intracellular fate of TCR-CD3 complexes. Crit Rev Immunol 2000; 20: 325-346.
21. Chakrabandhu K, Huault S, Garmy N, Fantini J, Stebe E, Mailfert S et al. The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand. Cell Death Differ 2008; 15: 1824-1837.
22. Rossin A, Kral R, Lounnas N, Chakrabandhu K, Mailfert S, Marguet D et al. Identification of a lysine-rich region of Fas as a raft nanodomains targeting signal necessary for Fas-mediated cell death. Exp Cell Res 2010; 316: 1513-1522.
23. Shinohara H, Yagita H, Ikawa Y, Oyaizu N. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. Cancer Res 2000; 60: 1766-1772. (Pubitemid 30183454)
24. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M et al. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000; 10: 640-648. (Pubitemid 30354699)
25. Newton K, Strasser A. Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev 2003; 17: 819-825. (Pubitemid 36397369)
26. Thome M, Tschopp J. TCR-induced NF-kappaB activation: a crucial role for Carma1, Bcl10 and MALT1. Trends Immunol 2003; 24: 419-424. (Pubitemid 36928098)
27. Zhang N, Hopkins K, He YW. c-FLIP protects mature T lymphocytes from TCR-mediated killing. J Immunol 2008; 181: 5368-5373.
28. Maksimow M, Santanen M, Jalkanen S, Hanninen A. Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells. Blood 2003; 101: 4022-4028. (Pubitemid 36857881)
29. Cancedda C, LeMaoult J, Harris PE, Suciu-Foca N, Cortesini R. Specific T-cell deletion by transfected human monocytes expressing Fas ligand and antigen. Transplant Proc 2001; 33: 165-166. (Pubitemid 32237317)
30. Chen A, Zheng G, Tykocinski ML. Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses. Cell Immunol 2003; 221: 128-137. (Pubitemid 36549088)
31. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bornard T et al. Activated B cells express functional Fas ligand. Eur J Immunol 1996; 26: 721-724. (Pubitemid 26091406)
32. Suss G, Shortman K. A subclass of dendritic cells kills CD4T cells via Fas/Fas-ligandinduced apoptosis. J Exp Med 1996; 183: 1789-1796.
33. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996; 70: 199-206. (Pubitemid 126508786)
34. Hoves S, Krause SW, Herfarth H, Halbritter D, Zhang HG, Mountz JD et al. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells. Immunobiology 2004; 208: 463-475. (Pubitemid 38515030)
35. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 2001; 15: 997-1009. (Pubitemid 34075379)
36. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W et al. Monoclonal antibodymediated tumor regression by induction of apoptosis. Science 1989; 245: 301-305. (Pubitemid 19196649)
37. Paulsen M, Mathew B, Qian J, Lettau M, Kabelitz D, Janssen O. FasL cross-linking inhibits activation of human peripheral T cells. Int Immunol 2009; 21: 587-598.
38. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157-163. (Pubitemid 29068521)
39. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274: 1541-1548.
40. Scaffidi C, Medema JP, Krammer PH, Peter ME. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 1997; 272: 26953-26958. (Pubitemid 27452647)